Stunning and I-123 use for diagnostic whole body scanning [1]

Thyroid

Volumn 16, Issue 8, 2006, Pages 817-

  Gerard, Stephen K ^a   Park, Hee Myung ^b  

^a Seton Medical Center   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 123;

DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; LETTER; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY; THYROID DISEASE; THYROID STUNNING; WHOLE BODY SCINTISCANNING;

HUMANS; IODINE RADIOISOTOPES; POSTOPERATIVE PERIOD; RADIOMETRY; RADIOPHARMACEUTICALS; THYROID NODULE; TREATMENT OUTCOME; WHOLE BODY IMAGING;

EID: 33751025112     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.817     Document Type: Letter

References (6)

1. Cooper SD, Doherty GM, Haugen BR, et al. 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 15:1-33.
2. Muratet JP, Daver A, Minier JF, Larra F 1998 Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma. J Nucl Med 39:1546-1550.
3. Lees W, Mansberg R, Roberts J, Towson J, Chua E, Turtle J 2002 The clinical effects of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I. Eur J Nucl Med 29:1421-1427.
4. Hilditch TE, Dempsey MF, Bolster AA, McMenemin RM, Reed NS 2002 Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I. Eur J Nucl Med 29:783-788.
5. MIRD (Medical Internal Radiation Dose) Committee 1975 Report #5. Summary of current radiation dose estimates to humans from 123I, 124I, 125I, 126I 130I, 131I, and 132I as sodium iodide. J Nucl Med 16:857-860.
6. 131I thyroid imaging prior to radioablation therapy. In: Wartofsky L, Van Nostrand D (eds) Thyroid Cancer: A Comprehensive Guide to Clinical Management. Humana Press, Totowa, NJ, pp. 337-345.